发文地区与机构
近年国家 / 地区发文量统计
| 国家 / 地区 | 发文量 |
|---|---|
| CHINA MAINLAND | 312 |
| GERMANY (FED REP GER) | 223 |
| USA | 105 |
| Italy | 80 |
| South Korea | 60 |
| Japan | 55 |
| Switzerland | 55 |
| France | 31 |
| England | 25 |
| Spain | 25 |
近年机构发文量统计
| 机构 | 发文量 |
|---|---|
| FRIEDRICH SCHILLER UNIVERSITY OF JENA | 36 |
| UNIVERSITY OF MUNICH | 35 |
| FUDAN UNIVERSITY | 31 |
| RUPRECHT KARLS UNIVERSITY HEIDELBERG | 30 |
| HELMHOLTZ ASSOCIATION | 27 |
| SICHUAN UNIVERSITY | 24 |
| UNIVERSITY OF HAMBURG | 22 |
| SHANGHAI JIAO TONG UNIVERSITY | 21 |
| SUN YAT SEN UNIVERSITY | 21 |
| CHINESE ACADEMY OF MEDICAL SCIENCES - P... | 20 |
文章引用情况
1
Prognostic role of glycolysis for cancer outcome: evidence from 86 studies2
CD LAG and IDO1 expressions in tumor-infiltrating immune cells as prognostic biomarker for patients with MSI-high colon cancer3
Role of natural killer cells in lung cancer4
Long non-coding RNA HOTTIP affects renal cell carcinoma progression by regulating autophagy via the PI3K/Akt/Atg13 signaling pathway5
Everolimus in patients with multiply relapsed or cisplatin refractory germ cell tumors: results of a phase II, single-arm, open-label multicenter trial (RADIT) of the German Testicular Cancer Study Group6
MicroRNA-338-5p plays a tumor suppressor role in glioma through inhibition of the MAPK-signaling pathway by binding to FOXD17
Multigene panel testing beyond BRCA1/2 in breast/ovarian cancer Spanish families and clinical actionability of findings8
Clinical significance of circulatory microRNA-203 in serum as novel potential diagnostic marker for multiple myeloma9
C-reactive protein as an early marker of immune-related adverse events10
Patterns of breast cancer relapse in accordance to biological subtype